Objective-Increased reactive oxygen species (ROS) production is involved in the pathophysiology of endothelial dysfunction. NADPH oxidase-4 (Nox4) is a ROS-generating enzyme expressed in the endothelium, levels of which increase in pathological settings. Recent studies indicate that it generates predominantly hydrogen peroxide (H 2 O 2 ), but its role in vivo remains unclear. Methods and Results-We generated transgenic mice with endothelium-targeted Nox4 overexpression (Tg) to study the in vivo role of Nox4. Tg demonstrated significantly greater acetylcholine-or histamine-induced vasodilatation than wild-type littermates. This resulted from increased H 2 O 2 production and H 2 O 2 -induced hyperpolarization but not altered nitric oxide bioactivity. Tg had lower systemic blood pressure than wild-type littermates, which was normalized by antioxidants.
See accompanying article on page 1255
Nox family NADPH oxidases are major vascular ROS sources. 2, 3 Five distinct NADPH oxidases based on separate Nox catalytic isoforms (NADPH oxidase-1 [Nox1] to Nox5) have been described. Vascular cells express multiple Nox isoforms. Endothelial cells coexpress Nox2 (also known as gp91 phox ) and Nox4, whereas vascular smooth muscle cells express mainly Nox4 and Nox1, at least in rodents. [3] [4] [5] [6] Although Nox1, Nox2, and Nox4 exist as membrane-bound heterodimers with a p22 phox subunit, there are important differences between Nox4 and Nox1/2. Nox1 and Nox2 are normally quiescent and are activated by specific agonists (eg, angiotensin II [Ang II]) in a process that involves binding of regulatory cytosolic subunits. 2, 3 This initiates production of superoxide, which may react with NO or be converted to hydrogen peroxide (H 2 O 2 ) in the presence of superoxide dismutases (SODs). In contrast, Nox4 constitutively generates ROS without requiring activating cytosolic factors. [7] [8] [9] Furthermore, multiple recent reports indicate that Nox4 generates predominantly H 2 O 2 rather than superoxide. 7,8,10 -13 Nox1 and Nox2 are implicated in the development of endothelial dysfunction and hypertension in preclinical models and humans. 2, 3 Nox2 knockout mice have reduced endothelial dysfunction during experimental hypertension, 14 whereas p47 phox knockout mice (which have deficient Nox1 and Nox2 activation) exhibit reduced hypertension and preserved endothelial function after chronic Ang II treatment. 15 Nox1 knockout mice have a reduced basal blood pressure (BP), preserved endothelial function, and a reduced hypertensive response to Ang II infusion. 16, 17 Vascular smooth muscle-targeted Nox1 transgenic mice have enhanced vascular hypertrophy, hypertension, and endothelial dysfunction. 18, 19 Nox4 levels in the endothelium and vessel wall increase in several disease settings, 17, 20 but the effects of Nox4 on vascular function in vivo remain unknown.
In this study, we investigated the effects of a targeted increase in endothelial Nox4 expression on vascular function in vivo.
Methods
For detailed Methods, please see the supplemental materials, available online at http://atvb.ahajournals.org.
Procedures were performed in accordance with the Guidance on the Operation of the Animals (Scientific Procedures) Act, 1986 (United Kingdom Home Office).
Generation of Transgenic Mice With Endothelium-Targeted Nox4 Overexpression
Endothelium-targeted Nox4 overexpression was achieved using a tie2 promoter/enhancer construct. 21 We studied 8-to 16-week-old male transgenic mice with endothelium-targeted Nox4 overexpression (Tg) and matched wild-type (WT) littermate mice.
Real-Time Reverse Transcription-Polymerase Chain Reaction
mRNA quantitation was performed using the comparative Ct method. For primer sets, please see the supplemental materials.
Histology
Aortic wall thickness and cross-sectional area were measured from in vivo pressure-fixed specimens. 18 
ROS Measurements
H 2 O 2 production was measured using a homovanillic acid-based assay 9 or the ferrous oxidation-xylenol orange method. 22 In situ H 2 O 2 levels were assessed in coronary microvascular endothelial cells (CMEC) loaded with 5-(and 6)-chloromethyl-2Ј,7Јdichlorodrofluorescein diacetate. Endothelial cell superoxide production was measured using high-performance liquid chromatography-based detection of dihydroethidium oxidation products, ie, 2-hydroxyethidine and ethidium. 23 SOD activities in aortic homogenates were assayed by zymography. 24 
Vascular Tone
Isometric tension was measured in aortic segments and coronary vascular tone in isolated hearts perfused at constant flow.
Surgery and BP
Pressure transducers for BP telemetry were implanted via the left carotid artery. Ang II was administered via osmotic minipumps.
Statistics
Data are expressed as meanϮSEM. Comparisons between Tg and WT were made by unpaired Student t test for 2 groups, 1-way ANOVA with Bonferroni post hoc testing for more than 2 groups, or repeated-measures ANOVA. Two-way ANOVA was used to compare treatment responses between Tg and WT. Concentrationresponse curves were compared by nonlinear regression analysis followed by the extra sum-of-squares F test. PϽ0.05 was considered significant.
Results

Endothelium-Specific Overexpression of Nox4 In Vivo
Two independent Tg lines were generated (lines 1 and 2). Results were similar for the 2 lines, and data reported herein are for line 1. Tg were born in the expected mendelian ratios and had body weights and organ weights similar to those of WT littermates (eg, body weight 26.6Ϯ0.48 g in WT versus 27.5Ϯ0.50 g in Tg at age 12 weeks; nϭ22 per group; Pϭnot significant [NS]). Nox4 transgene expression in a range of organs tracked endothelial nitric oxide synthase (eNOS) mRNA level, as a marker of endothelial cell content, consistent with endothelium specificity-apart from heart, where cardiomyocytes also express eNOS (Supplemental Figure I) . Immunolabeled aortic sections showed increased Nox4 staining in the endothelium of Tg compared with WT (Supplemental Figures II and III). Tg CMEC had significantly greater Nox4 protein levels than WT (2.60Ϯ0.45 versus 1.00Ϯ0.11 arbitrary units; nϭ4; PϽ0.05) ( Figure 1A ).
Endothelial Nox4 Generates Predominantly H 2 O 2
Tg CMEC produced Ͼ2-fold more H 2 O 2 than WT by a homovanillic acid assay ( Figure 1B ). H 2 O 2 levels assessed by 5-(and 6)-chloromethyl-2Ј,7Ј-dichlorodrofluorescein diacetate fluorescence were also significantly higher in Tg CMEC ( Figure 1C ). H 2 O 2 levels in aorta assessed by a xylenol orange assay were significantly higher in Tg than WT ( Figure  1D ). To definitively address under carefully controlled conditions whether elevated endothelial Nox4 increases both superoxide and H 2 O 2 levels or only H 2 O 2 , we studied the effect of acute Nox4 elevation in human umbilical vein endothelial cells (HUVEC) ( Figure 1E ). We studied HUVEC rather than CMEC because adenoviral overexpression in the latter cell type is poorly reproducible. Nox4-overexpressing HUVEC generated more H 2 O 2 than control cells by homovanillic acid assay ( Figure 1E ). Using high-performance liquid chromatography-based detection of dihydroethidium oxidation products, 23 there was no significant difference in levels of superoxide-specific 2-hydroxyethidine in Nox4overexpressing versus ␤-galactosidaseoverexpressing cells ( Figure 1F ). However, levels of the ethidium oxidation product, which is related to H 2 O 2 -dependent oxidation, 23 were significantly higher after Nox4 overexpression, and this increase was abolished by catalase ( Figure 1F ).
A major difference between H 2 O 2 versus superoxide production by endothelial cells in vessels is the interaction with NO. Whereas superoxide reacts rapidly with NO in a diffusion-limited reaction to generate peroxynitrite, H 2 O 2 does not undergo this reaction. 25 We quantified nitrotyrosine levels in aortae as a readout of nitrosative/nitrative stress resulting from NO/superoxide interaction 25 but found no significant difference between Tg and WT ( Figure 1G ). However, levels of oxidized peroxiredoxin as a measure of chronic in situ H 2 O 2 production 26 were significantly higher in Tg aorta ( Figure 1H ). Taken together, these data indicate that endothelial Nox4 overexpression predominantly increases H 2 O 2 levels.
Nox Subunits, eNOS, and Antioxidant Status
We investigated whether Nox4 overexpression led to compensatory changes in other proteins that may influence the vascular response. Protein levels of p22 phox and Nox2 were similar in Tg and WT aorta (Supplemental Figure IVA and IVB), whereas Nox1 expression was below the detection limit. Nox2 and p22 phox levels in CMEC were also similar between groups (Supplemental Figure IB and IC). Neither eNOS nor phospho-eNOS levels were different between Tg and WT (Supplemental Figure IVA and IVB). The expression of the antioxidant enzymes SOD1 to SOD3 and catalase, which scavenge superoxide and H 2 O 2 , respectively, was similar in WT and Tg aorta (Supplemental Figure IVC) . Furthermore, SOD activity was no different between Tg and WT (Supplemental Figure IVD) .
Enhanced Endothelium-Dependent Relaxation in Tg
We next studied vascular function in aortic rings. Vasoconstriction to phenylephrine or prostaglandin F2␣ was similar in Tg and WT, as was vasodilatation to the NO donor sodium nitroprusside (Figure 2A-2C ). Maximal constriction to 80 mmol/L KCl was similar between groups (0.64Ϯ0.03 g in Tg versus 0.65Ϯ0.03 g in WT; nϭ12; PϭNS). However, vasodilatation to the endothelium-dependent agonist acetylcholine was enhanced in Tg, with a significantly greater potency ( Figure 2D ). In isolated retrogradely perfused hearts, where a reduction in coronary perfusion pressure at constant flow reflects a decrease in resistance vessel tone, acetylcholine-induced coronary vasodilatation was significantly enhanced in Tg versus WT ( Figure 2E ). Sodium nitroprusside-induced vasodilatation was similar between groups (Ϫ53.2Ϯ10.2% in Tg versus Ϫ58.2Ϯ4.7% in WT; nϭ5; PϭNS). The enhanced response to acetylcholine was not attributable to changes in M3-muscarinic receptors: mRNA expression by real-time polymerase chain reaction was 0.013Ϯ0.001 arbitrary units in WT versus 0.011Ϯ0.001 in Tg (nϭ3/group; PϭNS).
Enhanced Endothelium-Dependent Vasodilatation in Tg Results From Increased H 2 O 2
Because Nox4 elevation induced an increase in H 2 O 2 levels ( Figure 1 ) and H 2 O 2 can evoke or enhance endotheliumdependent relaxation through multiple mechanisms, 27 we investigated whether the enhanced vasodilatation in Tg was attributable to H 2 O 2 . In the presence of catalase to scavenge H 2 O 2 , the enhanced acetylcholine-induced relaxation in Tg aorta was abolished ( Figure 2F ). Vasodilatation to acetylcholine in isolated perfused hearts of Tg and WT was identical in the presence of catalase ( Figure 2G ). Vasodilatation to a different agonist, histamine, was also enhanced in Tg versus WT aorta, and this difference was abolished by catalase ( Figure 2H and 2I). 
Mechanism of H 2 O 2 -Dependent Enhancement of Vasorelaxation
In the presence of N G -monomethyl-L-arginine (L-NMMA; 100 mol/L) to inhibit NOS, the magnitude of acetylcholineinduced vasodilatation was reduced in both Tg and WT aorta, but residual vasodilatation remained significantly greater in Tg ( Figure 3A ). 1H-(1,2,4)oxadiazolo[4,3-a]quinoxalin-1one (ODQ, 5 mol/L), which inhibits soluble guanylate cyclase (the major downstream target of NO involved in vasodilatation), reduced acetylcholine-induced vasodilatation in both Tg and WT, but EC 50 remained greater in Tg ( Figure  3B ). An inhibitor of protein kinase G, KT5823 (2 mol/L), significantly reduced acetylcholine-induced vasodilatation, but vasodilatation remained greater in Tg ( Figure 3C ). The combination of ODQ and catalase fully abolished acetylcholine-induced vasodilatation in both groups ( Figure  3D ). These results suggest that the enhanced vasodilatation in Tg is not due to increased NO bioactivity or increased activation of soluble guanylate cyclase or protein kinase G but involves some other action of H 2 O 2 .
To assess whether H 2 O 2 -induced hyperpolarization accounted for the enhanced vasodilatation, we studied the acetylcholine response in the presence of 30 mmol/L extracellular potassium. Under these conditions, acetylcholineinduced vasodilatation was identical in Tg and WT ( Figure  3E ). Acetylcholine-induced vasodilatation was fully abolished in the combined presence of high extracellular potassium and ODQ ( Figure 3F ). Vasodilation to acetylcholine in Tg and WT rings was identical in the combined presence of charybdotoxin (100 nmol/L, which blocks large and intermediate-conductance K Ca channels) and apamin (1 mol/L, which blocks small-conductance K Ca channels) [27] [28] [29] (Figure 3G) . A similar normalization of histamine-induced vasodilatation was also observed in the presence of these blockers ( Figure 3H ). Taken together, these results indicate that the enhanced vasodilatation to acetylcholine in Tg involves increased H 2 O 2 generation, which likely acts through hyperpolarization rather than enhanced NO, guanylate cyclase, or protein kinase G activities.
Tg Have a Reduced BP
Tg had a lower BP than WT littermates by tail cuff plethysmography (106.3Ϯ0.7 mm Hg versus 116.7Ϯ0.9 mm Hg; nՆ6; PϽ0.05), and BP was also significantly lower in the second line of Tg (by Ϸ12 mmHg; PϽ0.05; nϭ7). Telemetric ambulatory BP measurements confirmed a significantly lower BP in Tg ( Figure 4A and 4B and Supplemental Figure  V) . This difference was present during night-time and daytime periods and was not attributable to differences in heart rate or activity level (Supplemental Figure V) .
Plasma and urinary sodium and urinary volumes were similar in WT and Tg ( Figure 4C ), suggesting that the lower BP was not accounted for by altered renal sodium or fluid excretion. The lower BP in Tg was not attributable to vascular structural remodeling, as there was no difference in vessel wall thickness or cross-sectional area between groups ( Figure  4D ). We assessed whether the lower BP in Tg was the result of increased NO bioavailability. However, plasma nitrite/ nitrate levels (as a marker of NO production) were similar between groups ( Figure 4E ). The levels of phosphorylated vasodilator-stimulated phosphoprotein in aorta, as a readout of bioavailable NO and protein kinase G activity, were similar between groups ( Figure 4F ). Vascular cGMP levels quantified by enzyme-immunoassay were also similar ( Figure  4G ). Furthermore, the vascular response to L-NMMA in lightly constricted aortic rings, as a functional readout of basal NO bioactivity, showed no difference between Tg and WT ( Figure 4H ).
Acute in vivo inhibition of NO production with L-NMMA (10 mg/kg IV) in anesthetized mice increased systolic BP to a similar extent in Tg and WT ( Figure 5A ), and BP remained significantly lower in Tg (difference in BP 13.2Ϯ1.6 mm Hg at baseline versus 16.7Ϯ1.8 mm Hg in the presence of L-NMMA; nϭ5). To ascertain whether the lower BP in Tg resulted from increased ROS production per se, mice were treated with either of 2 structurally distinct antioxidants-Nacetylcysteine (5 g/L in drinking water) or a salen-manganese-based SOD/catalase mimetic EUK-8 (25 mg/kg per day IP) 30 -over a 7-day period. In the presence of N-acetylcysteine, BP was reduced in WT but increased in Tg such that the difference between groups was attenuated ( Figure 5B ). On withdrawal of N-acetylcysteine, the baseline difference in BP between Tg and WT was restored. EUK-8 also caused a reduction in BP in WT but a slight increase in Tg such that the difference in BP between groups was abolished; the difference in BP between groups was restored on removal of EUK-8 ( Figure 5B ). Chronic treatment with N-acetylcysteine reduced aortic nitrotyrosine levels in both WT and Tg ( Figure 5C ), consistent with a reduction in superoxide levels. N-Acetylcysteine abolished the elevation in H 2 O 2 levels in Tg aorta ( Figure 5D ).
Effect of Endothelial Nox4 Overexpression on Ang II-Induced Hypertension
To assess the impact of Nox4 overexpression in a pathological setting, we examined BP during chronic Ang II infusion (1.1 mg/kg per day SC). The hypertensive response to Ang II was biphasic, with an initial rapid rise followed by a slower sustained increase ( Figure 6A to 6C). The initial phase was absent in Tg (significant interaction by 2-way ANOVA), whereas the later phase appeared similar to that of WT, albeit at a lower level of BP. Ang II-induced increases in aortic wall thickness were similar between groups ( Figure 6D ).
Discussion
We have undertaken the first direct investigation of the in vivo effects of Nox4 on vascular function, using genemodified mice with endothelium-targeted Nox4 overexpression. The principal findings are that an increase in endothelial Nox4 and associated H 2 O 2 production results in enhanced vasodilator function and a lower basal BP. These effects contrast markedly with those previously reported for vascular Nox1 and Nox2 and suggest that increases in Nox4 may potentially be beneficial as compared with other Noxs.
Tg had increases in Nox4 levels in a similar range to that previously observed in various vascular disease settings. 17, 20 Increased Nox4 expression was not associated with significant changes in vascular expression of other Nox isoforms, SOD1 to SOD3, catalase, or eNOS, suggesting that no major compensatory changes occurred in these pathways, unlike previous studies in which p22 phox was overexpressed in vascular smooth muscle. 31 Previous work suggests that forced increases in Nox subunit expression may be accompanied by an increase in p22 phox protein levels, because the 2 proteins stabilize each other in a complex. 2 We did not observe increased p22 phox levels which could be because the level of increase in Nox4 was modest. Tg had significantly enhanced aortic vasodilatation to the endothelium-dependent agonists acetylcholine and histamine, whereas smooth muscle relaxation to sodium nitroprusside was unaffected. This enhanced vasorelaxation was attributable to increased H 2 O 2 generation, and Tg produced significantly more H 2 O 2 than WT. Enhanced relaxation in Tg also extended to the resistance vasculature, as assessed in isolated hearts.
Many recent independent reports indicate that Nox4 generates predominantly H 2 O 2 rather than superoxide, in contrast to Nox1 and Nox2, which generate superoxide. 7,8,10 -13 The basis for predominant H 2 O 2 production by Nox4 remains incompletely understood, but studies with chimeric constructs Aortic rings were incubated with the agents indicated, and then ACh-induced relaxation was assessed. Relaxation was assessed in the presence of the following: A, L-NMMA (100 mol/L) (Ϫlog EC 50 7.45Ϯ0.01 Tg, 6.94Ϯ0.01 WT); B, ODQ (5 mol/L) (Ϫlog EC 50 6.84Ϯ0.11 Tg, 6.67Ϯ0.06 WT); C, KT5823 (2 mol/L) (Ϫlog EC 50 7.75Ϯ0.11 Tg, 7.26Ϯ0.12 WT); D, ODQ (5 mol/L)ϩcatalase (1500 IU/mL); E, KCl (30 mmol/L) (Ϫlog EC 50 7.24Ϯ0.01 Tg, 7.17Ϯ0.01 WT); F, KCl (30 mmol/ L)ϩODQ (5 mol/L); G, apamin (1 mol/L) and charybdotoxin (100 nmol/L) (Ϫlog EC 50 7.49Ϯ0.22 Tg, 7.32Ϯ0.19 WT); H, as in G but with histamine as agonist (Ϫlog EC 50 3.96Ϯ0.28 Tg, 3.87Ϯ0.15 WT). **PϽ0.01 comparing log EC 50 ; nՆ5.
of Nox4 with other Nox isoforms suggest that its activation mechanism is significantly different, such that H 2 O 2 is generated without intermediate superoxide production. [11] [12] [13] A different intracellular location of Nox4 compared with Nox1/2 could also be important, although a careful comparative study of superoxide versus H 2 O 2 production by Nox1 and Nox4 in membrane fractions (where intracellular location is not a factor) also showed mainly H 2 O 2 production by Nox4. 10 Consistent with these data in other cell types, we found that Nox4 elevation in endothelial cells resulted in an increase in H 2 O 2 production with hardly any detectable change in superoxide using a well-validated highperformance liquid chromatography-based method for the detection of dihydroethidium oxidation products. Consistent with predominant H 2 O 2 rather than superoxide production in Tg vessels in situ, we found an increased level of oxidized peroxiredoxin (as a readout for chronic H 2 O 2 production 26 ) but no difference in nitrotyrosine levels, as a readout of nitrosative stress resulting from the interaction of superoxide with NO to generate peroxynitrite. 25 H 2 O 2 induces vasodilatation in various murine and human vessels, 27 and endogenous H 2 O 2 may act as an endotheliumderived vasodilator. 28, 29, 32 H 2 O 2 -induced vasodilatation involves different mechanisms, including altered eNOS expression/activation or the activation of soluble guanylate cyclase or protein kinase G, the downstream targets of NO responsible for vasodilatation. 27 Our data suggest that the enhanced acetylcholine-induced vasodilatation in Tg did not result from these mechanisms because the difference between Tg and WT persisted after inhibition of NOS, soluble guanylate cyclase, or protein kinase G. However, enhanced acetylcholine-induced vasodilatation was abolished in the presence of high extracellular potassium or with K Ca channel blockers, consistent with H 2 O 2 -induced hyperpolarization. [27] [28] [29] H 2 O 2 -dependent "endothelium-derived hyperpolarizing factor-type" activity could occur through several mechanisms. Some workers suggest that the response involves diffusion of H 2 O 2 from endothelium to vascular smooth muscle, resulting in smooth muscle hyperpolarization. 28 Others propose that the endothelium-derived hyperpolarizing factor phenomenon is underpinned by endothelial hyperpolarization, which spreads electrotonically through the vessel wall via myoendothelial and homocellular smooth muscle gap junctions. 32 These authors showed that H 2 O 2 potentiates vasorelaxation by enhancing Ca 2ϩ release from endothelial endoplasmic reticulum stores, which in turn potentiates the opening of Ca 2ϩ -activated K ϩ channels. 32 Interestingly, with this mechanism, there is no basal effect of H 2 O 2 in the absence of agonist-induced relaxation. Although we did not directly address this mechanism, it is intriguing in view of the reported endoplasmic reticular location of endothelial Nox4. 8, 9 Tg also had a significantly lower basal BP than WT, which was not attributable to alterations in renal sodium or fluid excretion or to vascular structural remodeling. Increased NO bioactivity could theoretically lead to reduced vascular tone and lower BP, but our studies did not support this mechanism on the basis of unaltered plasma nitrite/nitrate levels; levels of vascular phosphorylated vasodilator-stimulated phosphoprotein, phospho-eNOS, and cGMP; assessment of basal NO bioactivity in aortic rings; and the BP response to acute NOS blockade. Instead, the difference in BP between WT and Tg was attributable to ROS generation per se in that short-term treatment with either of 2 structurally distinct antioxidants attenuated the difference in BP between groups. The effects of systemic antioxidant treatment were complex in that both agents reduced BP in WT animals but increased it in Tg. An explanation for these findings may be that in WT mice the scavenging of superoxide from Nox1 and Nox2 (and possibly other sources) reduces BP, whereas in Tg this effect is outweighed by the scavenging of Nox4-derived vasodilator H 2 O 2 . Consistent with this possibility, we found that chronic N-acetylcysteine treatment reduced aortic nitrotyrosine levels in both groups, whereas H 2 O 2 levels were reduced in the Tg group. It is tempting to link the effects of increased Nox4 expression on ex vivo vasodilator function with those on BP in vivo, but ROS-dependent pathways in the kidneys and brain are also important in BP regulation. 33, 34 Therefore, it is feasible that endothelium-targeted Nox4 overexpression could have an impact on pathways in those organs.
The role of Nox enzymes in hypertension has attracted significant attention. 2,3,14 -20 Good evidence supports a link between Nox1 and hypertension, 16 -18 whereas increased Nox2 activation is especially implicated in endothelial dys- function. 14, 15 Nox4 levels increase in Ang II-induced hypertension, 17 but there has so far been no direct data on possible functional effects. We found that during 2 weeks of Ang II infusion, Tg had a blunted initial hypertensive response but a similar pattern of later rise in BP to WT, albeit at a lower absolute level. The delayed rise in BP may be related to vascular structural remodeling, which was indeed similar between Tg and WT. The BP response to Ang II in Tg contrasts to previously reported effects of Nox2 and Nox1, which enhance hypertension. 14 -18 It therefore seems possible that increases in Nox4 could act to buffer rises in BP. Interestingly, Nox4 expression was reported to be elevated in basilar arteries of spontaneously hypertensive rats, and the application of NADPH to these vessels induced H 2 O 2dependent vasodilatation. 35 The importance of increased ROS production as a pathogenic mechanism in vascular diseases is well recognized, and the targeting of NADPH oxidases is considered to be a promising therapeutic approach. However, it has recently become apparent that Nox4 is different from other vascular Nox isoforms in terms of its biochemical activity. The current results suggest that an elevation of Nox4 levels in endothelial cells has quite different functional effects from Nox1 and Nox2 and that these may be potentially beneficial for vascular function. The key mechanism underlying the vasodilator effect of Nox4 is its propensity to produce predominantly H 2 O 2 rather than superoxide which means that, on the one hand, there is little or no inactivation of NO by superoxide, whereas on the other, H 2 O 2 induces vasodilatation through enhancement of hyperpolarization. In contrast, superoxide generated by Nox1 and Nox2 is much more likely to react with NO and inactivate it than to be converted to H 2 O 2 because the rate constant for the former reaction is much greater than for the latter. 23 The overall effects of changes in Nox levels will of course also depend on the different cell types within which Nox levels are altered. In conclusion, our results establish a novel paradigm for Nox4-dependent effects in the vasculature and indicate that therapeutic strategies to modulate ROS production in vascular disease need to take into account the potential for both beneficial and detrimental effects.
